SCHEMBL413130

SCHEMBL413130

C[C@H](Nc1cccc2c1ccc1ccccc12)C(=O)O.C[C@H](Nc1cccc2c1ccc1ccccc12)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 2/20 0.47
CA12 O43570 1/20 0.45
CA2 P00918 1/20 0.45
MMP2 P08253 1/20 0.45
MMP9 P14780 1/20 0.45
MMP8 P22894 1/20 0.45
MMP14 P50281 1/20 0.45
CA14 Q9ULX7 1/20 0.45
MAPT P10636 5/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
KDM4E B2RXH2 3/20 0.44
TNNI3 P19429 1/20 0.44
TNNT2 P45379 1/20 0.44
TNNC1 P63316 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
AKR1B1 P15121 1/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29494080 1.00 HPRT1 (0.47) HPRT1CA12CA2MMP2MMP9
SCHEMBL298855 0.91 CA12 (0.54) CA12CA2MMP2MMP9MMP8
SCHEMBL29367675 0.91 CA12 (0.54) CA12CA2MMP2MMP9MMP8
SCHEMBL29478385 0.91 CA12 (0.54) CA12CA2MMP2MMP9MMP8
SCHEMBL42287 0.91 CA12 (0.54) CA12CA2MMP2MMP9MMP8
SCHEMBL409050 0.91 CA12 (0.54) CA12CA2MMP2MMP9MMP8
SCHEMBL42286 0.91 CA12 (0.54) CA12CA2MMP2MMP9MMP8
Ammonia Solution, Strong SCHEMBL466943 0.89 CA12 (0.53) CA12CA2MMP2MMP9MMP8
Hydrochloric Acid SCHEMBL21433625 0.89 CA12 (0.53) CA12CA2MMP2MMP9MMP8
Hydrochloric Acid SCHEMBL21433626 0.89 CA12 (0.53) CA12CA2MMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210030918-A1 COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2021-02-04 US claimed
US-20170209845-A1 FORMATION OF ORGANIC NANOSTRUCTURE ARRAY RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2017-07-27 US claimed
EP-2089418-B1 FORMATION OF ORGANIC NANOSTRUCTURE ARRAY UNIV RAMOT (IL) 2016-11-09 EP claimed
EP-2961433-A1 PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF Ramot at Tel-Aviv University Ltd. (IL) 2016-01-06 EP claimed
US-9074095-B2 Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) 2015-07-07 US claimed
WO-2014132262-A1 PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-09-04 WO claimed
EP-2575909-A1 MALLEABLE HYDROGEL HYBRIDS MADE OF SELF-ASSEMBLED PEPTIDES AND BIOCOMPATIBLE POLYMERS AND USES THEREOF Ramot at Tel Aviv University, Ltd. (IL) 2013-04-10 EP claimed
US-20130079421-A1 MALLEABLE HYDROGEL HYBRIDS MADE OF SELF-ASSEMBLED PEPTIDES AND BIOCOMPATIBLE POLYMERS AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2013-03-28 US claimed
WO-2011151832-A1 MALLEABLE HYDROGEL HYBRIDS MADE OF SELF-ASSEMBLED PEPTIDES AND BIOCOMPATIBLE POLYMERS AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2011-12-08 WO claimed
US-20090175785-A1 Self-Assembled Fmoc-Ff Hydrogels RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2009-07-09 US claimed
EP-1973928-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS Ramot at Tel-Aviv University Ltd. (IL) 2008-10-01 EP claimed
WO-2007043048-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-04-19 WO claimed
US-20240167062-A1 HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2024-05-23 US disclosed
WO-2023166513-A1 PEPTIDE-BASED BIOINK COMPOSITIONS RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2023-09-07 WO disclosed
WO-2023135601-A1 PEPTIDE-CONTAINING HYBRID HYDROGEL FOR BONE REGENERATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2023-07-20 WO disclosed
US-20210030918-A1 COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2021-02-04 US disclosed
EP-1973928-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS Ramot at Tel-Aviv University Ltd. (IL) 2008-10-01 EP disclosed
WO-2008068752-A2 FORMATION OF ORGANIC NANOSTRUCTURE ARRAY RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2008-06-12 WO disclosed
US-20070138007-A1 Peptide nanostructure-coated electrodes RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-06-21 US disclosed
WO-2007043048-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240167062-A1 HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION HIF1A, HAO2, EGLN2 HPRT1 2142/4885CA12 593/4885CA2 200/4885
US-20210030918-A1 COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION VIP, NPPA, IAPP HPRT1 4816/4885CA12 900/4885CA2 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.